Bacterial infection promotes tumorigenesis of colorectal cancer via regulating CDC42 acetylation

PLoS Pathog. 2023 Feb 22;19(2):e1011189. doi: 10.1371/journal.ppat.1011189. eCollection 2023 Feb.

Abstract

Increasing evidence highlights the role of bacteria in promoting tumorigenesis. The underlying mechanisms may be diverse and remain poorly understood. Here, we report that Salmonella infection leads to extensive de/acetylation changes in host cell proteins. The acetylation of mammalian cell division cycle 42 (CDC42), a member of the Rho family of GTPases involved in many crucial signaling pathways in cancer cells, is drastically reduced after bacterial infection. CDC42 is deacetylated by SIRT2 and acetylated by p300/CBP. Non-acetylated CDC42 at lysine 153 shows an impaired binding of its downstream effector PAK4 and an attenuated phosphorylation of p38 and JNK, consequently reduces cell apoptosis. The reduction in K153 acetylation also enhances the migration and invasion ability of colon cancer cells. The low level of K153 acetylation in patients with colorectal cancer (CRC) predicts a poor prognosis. Taken together, our findings suggest a new mechanism of bacterial infection-induced promotion of colorectal tumorigenesis by modulation of the CDC42-PAK axis through manipulation of CDC42 acetylation.

MeSH terms

  • Acetylation
  • Carcinogenesis
  • Cell Transformation, Neoplastic
  • Colorectal Neoplasms*
  • Humans
  • Salmonella Infections*
  • Signal Transduction
  • cdc42 GTP-Binding Protein* / metabolism
  • p21-Activated Kinases / metabolism

Substances

  • cdc42 GTP-Binding Protein
  • p21-Activated Kinases
  • PAK4 protein, human
  • CDC42 protein, human

Grants and funding

This work was supported by grants from the National Natural Science Foundation of China 31900111 (to DW), 81830068 (to YY), 81772140 (to YY), 81501733 (to JLu), and 31700121 to (to JN), Key Research and Development Project of China (No. 2016YFA0500600) (to YY), the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (to YY), GuangCi Professorship Program of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (to YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.